Physician profile
Robert J Lindeman
NPI 1932124211
$826.50
in general payments reported to CMS, 2019-2025
20 companies · $92.54 in 2025
The $92.54 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.73 · 2020: $48.71 · 2021: $77.28 · 2022: $112 · 2023: $145 · 2024: $314 · 2025: $92.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $198.74 | 2021-2024 | Azstarys |
| Pfizer INC. | $133.43 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $58.16 | 2023-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Sanofi Pasteur INC. | $54.35 | 2022-2023 | |
| Ironshore Pharmaceuticals INC. | $44.76 | 2024 | |
| Novo Nordisk INC | $41.55 | 2021-2024 | Wegovy, Saxenda |
| Glaxosmithkline, LLC. | $34.37 | 2024-2025 | Arexvy, Shingrix, Penmenvy |
| Takeda Pharmaceuticals U.S.A., INC. | $33.57 | 2021 | |
| Supernus Pharmaceuticals, INC. | $28.42 | 2021-2023 | Qelbree |
| Tris Pharma INC | $27.31 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.11 | 2020 | |
| Sobi, INC | $22.75 | 2019 | |
| Dexcom, INC. | $21.59 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $18.58 | 2024 | Mounjaro, Basaglar, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.42 | 2024 | Caplyta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $15.22 | 2022 | |
| Smith+Nephew, INC. | $15.10 | 2025 | Mini-Open Latarjet |
| Abbvie INC. | $14.37 | 2020 | |
| Hologic Sales and Service, LLC | $13.47 | 2025 | Acessa Provu System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lindeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.